Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 203-313-2
CAS number: 105-60-2
Table 1: Mortality rate in males
Dose (mg/kg bw)
Table 2: Mortality rates in females
This study was performed according to guideline and GLP. The LD50 for
male and female rats was reported to be 1876 and 1475 mg/kg bw,
respectively. Significant mortality was observed from the dose level of
1600 mg/kg bw within 6 h after exposure. Clinical signs were clonic
convulsion, piloerection, salivation, dyspnoea, tremor, high stepping
gait, nose discharge, hollow flanks. The signs were persistent until the
end of the 7 days observation period. At necropsy, redness in the lungs
and gastro-intestinal tract, and enlarged liver were described.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
Welcome to the ECHA website. This site is not fully supported in Internet Explorer 7 (and earlier versions). Please upgrade your Internet Explorer to a newer version.
Do not show this message again